Abstract: Objectives: Thrombolysis treatment for patients with mild stroke is controversial. The aim of our study was to investigate the clinical characteristics and influencing factors of early neurological deterioration (END) in this group of patients.
Methods: A retrospective analysis was performed on ischemic stroke patients with intravenous thrombolysis (IVT) in Wenzhou Central Hospital. Subgroup analyses were performed for the mild stroke group and nonmild stroke group, END group, and non-early neurological deterioration group in mild stroke patients, respectively.
Results: A total of 498 patients were included in this study. Compared with the control group, the mild stroke group was younger age, less atrial fibrillation, previous history of stroke and less use of antithrombotic drugs, more dyslipidemia, smoking, and drinking. Small artery occlusion type was more common in mild stroke, cardioembolism and stroke of undetermined etiology type were less. In the mild stroke group, the symptomatic intracerebral hemorrhage (sICH) rate was 2.54%, and the END rate was 16.1%. Predictors of END included systolic blood pressure, blood glucose, cardioembolism subtype, sICH, and large vessel occlusion. In END patients, the sICH rate was 10.53%, and 84.21% of cases started to worsen within 12 hours after IVT. There was no statistically significant difference in the time to exacerbation among different subtypes.
Conclusions: The occurrence of mild stroke in young patients was largely related to unhealthy lifestyles. The incidence of END in mild stroke IVT patients was low, with most occurring within 12 hours of IVT. There were many risk factors for END: large vessel occlusion and hyperglycemia were independent risk factors for END after IVT. sICH was an important but rare risk factor for END.
Competing Interests: The authors declare no conflict of interest.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
References: Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:3331–3332.
Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018. Chin J Neurol. 2018;51:666–682.
Tong DC. Avoiding thrombolysis in patients with mild stroke: is it SMART? Stroke. 2012;43:625–626.
Urra X, Arino H, Llull L, et al. The outcome of patients with mild stroke improves after treatment with systemic thrombolysis. PLoS One. 2013;8:e59420.
Nanri Y, Yakushiji Y, Hara M, et al. Stroke scale items associated with neurologic deterioration within 24 h after recombinant tissue plasminogen activator therapy. J Stroke Cerebrovasc Dis. 2013;22:1117–1124.
Wang YL, Zhao XQ, Liu XF, et al. Guidelines for the diagnosis and treatment of high-risk nondisabling ischemic cerebrovascular events. Chin J Stroke. 2016;11:481–491.
Gao DD, Li Y, Ma QF, et al. Effect of prehospital transport mode on delay care in patients with acute stroke in a tertiary hospital in Beijing. Chin J Cerebrovasc Dis. 2017;14:113–117.
Davalos A, Toni D, Iweins F, et al. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke. 1999;30:2631–2636.
Grotta JC, Welch KM, Fagan SC, et al. NINDS rt-PA Stroke Study Group. Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke. 2001;32:661–668.
Yu WM, Abdul-Rahim AH, Cameron AC, et al. The incidence and associated factors of early neurological deterioration after thrombolysis: results from SITS Registry. Stroke. 2020;51:2705–2714.
Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay,age,and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–1935.
Mori M, Naganuma M, Okada Y, et al. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Cerebrovasc Dis. 2012;34:140–146.
Huang ZX, Wang QZ, Dai YY, et al. Early neurological deterioration in acute ischemic stroke: a propensity score analysis. J Chin Med Assoc. 2018;81:865–870.
Alvarez SJ, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003;34:1235–1241.
Ennis SR, Keep RF. Effect of sustained mild and transient severe hyperglycemia on ischemia induced blood brain barrier opening. J Cereb Blood Flow Metab. 2007;27:1573–1582.
Hou Q, Zuo Z, Michel P, et al. Influence of chronic hyperglycemia on cerebral microvascular remodeling: an in vivo study using perfusion computed tomography in acute ischemic stroke patients. Stroke. 2013;44:3557–3560.
Mazya MV, Cooray C, Lees KR, et al. Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register. Eur Stroke J. 2018;3:29–38.
Seners P, Ben Hassen W, Lapergue B, et al. Prediction of early neurological deterioration in individuals with minor stroke and large vessel occlusion intended for intravenous thrombolysis alone. JAMA Neurol. 2021;78:321–328.
Sweid A, Hammoud B, Ramesh S, et al. Acute ischaemic stroke interventions: large vessel occlusion and beyond. Stroke Vasc Neurol. 2019;5:80–85.
Nedeltchev K, Schwegler B, Haefeli T, et al. Outcome of stroke with mild or rapidly improving symptoms. Stroke. 2007;38:2531–2535.
Kim D-H, Lee D-S, Nah H-W, et al. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke. BMC Neurol. 2018;18:30.
Wang YL, Pan YS, Zhao XQ, et al. Recurrent stroke was associated with poor quality of life in patients with transient ischemic attack or minor stroke: finding from the CHANCE trial. CNS Neurosci Ther. 2014;20:1029–1035.
Saleem Y, Nogueira RG, Rodrigues GM, et al. Acute neurological deterioration in large vessel occlusions and mild symptoms managed medically. Stroke. 2020;51:1428–1434.
Gwak D-S, Choi WC, Kwon J-A, et al. Perfusion profile evaluated by severity-weighted multiple Tmax strata predicts early neurological deterioration in minor stroke with large vessel occlusion. J Cereb Blood Flow Metab. 2022;42:329–337.
Zhong LC, Wei L, Wen S, et al. Correlation study between small vessel disease and early neurological deterioration in patients with mild/moderate acute ischemic stroke. Int J Neurosci. 2017;127:579–585.
Del BA, Palumbo V, Lamassa M, et al. Progressive lacunar stroke:review of mechanisms, prognostic features, and putative treatments. Int J Stroke. 2012;7:321–329.
Liu J, Shi Q, Sun Y, et al. Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28:1126–1132.
Processing Request
No Comments.